Healthcare provider profile · identity verified

Leah B Jacobs, NP

Nurse Practitioner · WEBSTER, WI · NPI 1255627972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	306	87
Amlodipine Besylate	Amlodipine Besylate	242	57
Levothyroxine Sodium	Levothyroxine Sodium	234	58
Omeprazole	Omeprazole	225	61
Losartan Potassium	Losartan Potassium	204	56
Lisinopril	Lisinopril	192	51
Metoprolol Succinate	Metoprolol Succinate	188	52
Gabapentin	Gabapentin	173	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	129	23
Metformin Hcl	Metformin Hcl	122	34
Simvastatin	Simvastatin	112	26
Furosemide	Furosemide	110	38
Albuterol Sulfate Hfa	Albuterol Sulfate	92	33
Hydrochlorothiazide	Hydrochlorothiazide	89	25
Metoprolol Tartrate	Metoprolol Tartrate	84	19
Tramadol Hcl	Tramadol Hcl	84	14
Oxycodone Hcl	Oxycodone Hcl	82	20
Potassium Chloride	Potassium Chloride	82	22
Ventolin Hfa	Albuterol Sulfate	73	20
Trulicity	Dulaglutide	67	12
Metformin Hcl Er	Metformin Hcl	61	16
Bupropion Xl	Bupropion Hcl	60	13
Warfarin Sodium	Warfarin Sodium	59	18
Atenolol	Atenolol	58	14
Pantoprazole Sodium	Pantoprazole Sodium	57	19
Sertraline Hcl	Sertraline Hcl	57	19
Spironolactone	Spironolactone	57	11
Pregabalin	Pregabalin	56	11
Tizanidine Hcl	Tizanidine Hcl	56	23
Duloxetine Hcl	Duloxetine Hcl	53	14
Ozempic	Semaglutide	53	13
Rosuvastatin Calcium	Rosuvastatin Calcium	53	14
Jardiance	Empagliflozin	52	suppressed
Montelukast Sodium	Montelukast Sodium	52	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	12
Clopidogrel	Clopidogrel Bisulfate	49	13
Lorazepam	Lorazepam	46	12
Tamsulosin Hcl	Tamsulosin Hcl	45	13
Celecoxib	Celecoxib	44	12
Fluoxetine Hcl	Fluoxetine Hcl	42	13
Glipizide Er	Glipizide	41	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Trazodone Hcl	Trazodone Hcl	40	17
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	22
Hydroxyzine Hcl	Hydroxyzine Hcl	38	15
Meloxicam	Meloxicam	38	suppressed
Eliquis	Apixaban	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Famotidine	Famotidine	36	13
Glimepiride	Glimepiride	36	11
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	16
Carvedilol	Carvedilol	35	11
Cephalexin	Cephalexin	34	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	11
Fluconazole	Fluconazole	32	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	31	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	31	23
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	20
Allopurinol	Allopurinol	30	11
Diazepam	Diazepam	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Nystatin	Nystatin	29	11
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	26	11
Synthroid	Levothyroxine Sodium	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	12
Xarelto	Rivaroxaban	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Ondansetron Odt	Ondansetron	23	11
Prednisone	Prednisone	22	14
Lidocaine	Lidocaine	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Azithromycin	Azithromycin	19	15
Methylprednisolone	Methylprednisolone	19	16
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Levofloxacin	Levofloxacin	18	14
Terazosin Hcl	Terazosin Hcl	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	15
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Estradiol	Estradiol	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Zaleplon	Zaleplon	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Glipizide	Glipizide	12	suppressed
Isibloom	Desogestrel-Ethinyl Estradiol	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Se-Natal 19	Pnv No.118/Iron Fumarate/Fa	12	suppressed
Tegretol Xr	Carbamazepine	12	suppressed
Torsemide	Torsemide	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Clonidine	Clonidine	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error